Topics

Acerta Pharma B.V. Company Profile

13:13 EDT 21st September 2019 | BioPortfolio

Acerta is a leader in the field of covalent binding technology and is applying this technology to create novel selective therapies intended for the treatment of cancer and autoimmune diseases. Acerta’s lead molecule, acalabrutinib (ACP-196), is a selective and potent inhibitor of Btk. Acerta is also developing ACP-319, a novel selective inhibitor of PI3k delta. The company has operations in Oss, the Netherlands and multiple U.S. sites. The U.S. headquarters is in Redwood City, CA.


News Articles [1058 Associated News Articles listed on BioPortfolio]

AZ's Acerta Pharma and Forty Seven enter lymphoma trial collaboration

Acerta Pharma BV (Astrazeneca PLC’s blood cancer R&D center of excellence) and Forty Seven Inc. penned a trial collaboration to investigate the combination of Forty Seven’s CD47 antibody Hu5F9-G4 ...

Forty Seven and Acerta to assess combination therapy for lymphoma

Immuno-oncology company Forty Seven has partnered with AstraZeneca’s Acerta Pharma to study a combination therapy for the treatment of diffuse...Read More... The post Forty Seven and Acerta to asses...

Calquence (acalabrutinib; AstraZeneca/Acerta) Overview and Product profile Report 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Calquence” report has been added to ResearchAndMarkets.com’s offering. Calquence (acalabrutinib; AstraZeneca/Acerta) is a novel, orally availa...

Forty Seven Inc. and Acerta Enter Collaboration to Evaluate Novel Immuno-Oncology Triple Combination in Diffuse Large B-cell Lymphoma

-- Plan to evaluate Forty Seven’s CD47 antibody in combination with rituximab and Calquence (acalabrutinib) -- -- Novel combination aims to leverage the macrophage component of the innate immune s...

AstraZeneca blood cancer drug hits study goal early

The results for Calquence help justify AstraZeneca's majority stake in Acerta, but chasing down Imbruvica remains a tall order.

FSD Pharma forms new alliance for pharma-grade cannabinoids

Canada-based FSD Pharma has signed a non-binding letter of intent (LOI) with algae technology company Solarvest BioEnergy for the development...Read More... The post FSD Pharma forms new alliance for ...

FSD Pharma: Tenbagger oder Rohrkrepierer?

FSD Pharma ist das Mutterunternehmen der FC Pharma Inc, welche ein lizensierter Marihuana Hersteller aus Kanada ist. Das Unternehmen ist auf die Produktion von Cannabis für den medizinischen Gebrau.....

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

Drugs and Medications [53 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 0.5 mg

Fluoride [mayne pharma inc]

Fluoride Chewable Tablets 1 mg

Urea [mayne pharma inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [aventis pharma ltd.]

NA

Ribavirin [aurobindo pharma limited]

NA

PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Data science tools and applications on the way to Pharma 4.0.

Multiple obstacles are driving the digital transformation of the biopharmaceutical industry. Novel digital techniques, often marketed as 'Pharma 4.0', are thought to solve some long-existing obstacles...

The Art of Virtualizing Pharma R&D.

Physicians in the pharmaceutical industry: their roles, motivations, and perspectives.

Although physicians occupy a significant number of key positions in the pharmaceutical industry, practicing clinicians are often unaware of the variety of career paths within this industry, or of the ...

Establishing and Maintaining a Robust Sample Management System.

This paper has been written by the SLAS Sample Management Special Interest Group to serve as a guide to the best practices and methods in establishing and maintaining a high-quality sample management ...

Potential effects of increased openness in pharma: the original knowledge behind new drugs.

This study seeks to determine potential changes in the degree of openness in pharmaceutical R&D by investigating where the knowledge behind new molecular entities (NMEs) comes from in terms of type of...

Clinical Trials [93 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [822 Associated Companies listed on BioPortfolio]

Acerta Pharma B.V.

Acerta is a leader in the field of covalent binding technology and is applying this technology to create novel selective therapies intended for the treatment of cancer and autoimm...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

More Information about "Acerta Pharma B.V." on BioPortfolio

We have published hundreds of Acerta Pharma B.V. news stories on BioPortfolio along with dozens of Acerta Pharma B.V. Clinical Trials and PubMed Articles about Acerta Pharma B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acerta Pharma B.V. Companies in our database. You can also find out about relevant Acerta Pharma B.V. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...


Corporate Database Quicklinks



Searches Linking to this Company Record